Press Releases
View printer-friendly version << Back
Avadel Pharmaceuticals to Present at BIO Digital
The presentation will focus on the development of once-nightly FT218 and positive results from the Phase 3 Rest-On clinical trial. The presentation will be available on-demand during the conference via https://www.bio.org/events/bio-digital/sessions/693802.
About Avadel Pharmaceuticals plc:
Contacts: | |
Investor Contacts Chief Financial Officer Phone: (636) 449-1843 Email: tmchugh@avadel.com |
|
Phone: (212) 915.2564 Email: tim@lifesciadvisors.com |
|
Media Contact Phone: (646) 970-4688 Email: pbursey@lifescicomms.com |
Source: Avadel Pharmaceuticals plc